Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in Lancet Retrieve available abstracts of 58 articles: HTML format Text format

Single Articles

January 2018
1. BROWN DL, Redberg RF
   Last nail in the coffin for PCI in stable angina?
   Lancet. 2018;391:3-4.
   PubMed     Text format    
   
   
   December 2017
2. DE WINTER RJ, Katagiri Y, Asano T, Milewski KP, et al
   A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 tri
   Lancet. 2017 Dec 1. pii: S0140-6736(17)33103.
   PubMed     Text format     Abstract available
   
   
   November 2017
3. AL-LAMEE R, Thompson D, Dehbi HM, Sen S, et al
   Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
   Lancet. 2017 Nov 1. pii: S0140-6736(17)32714.
   PubMed     Text format     Abstract available
   
   
   October 2017
4. VARENNE O, Cook S, Sideris G, Kedev S, et al
   Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
   Lancet. 2017 Oct 31. pii: S0140-6736(17)32713.
   PubMed     Text format     Abstract available
   
   
   April 2017
5. ALI ZA, Maehara A, Mintz GS, Stone GW, et al
   Optical coherence tomography-guided PCI - Authors' reply.
   Lancet. 2017;389:1608.
   PubMed     Text format    
   
   
   
6. SHAH R
   Optical coherence tomography-guided PCI.
   Lancet. 2017;389:1607.
   PubMed     Text format    
   
   
   November 2016
7. HERZEELE IV, Vermassen F
   Selection, technique, and follow-up: keys to success in EVAR.
   Lancet. 2016;388:2326-2328.
   PubMed     Text format    
   
   
   
8. PATEL R, Sweeting MJ, Powell JT, Greenhalgh RM, et al
   Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.
   Lancet. 2016;388:2366-2374.
   PubMed     Text format     Abstract available
   
   
   
9. GEORGE J
   Antibiotic-impregnated catheters for prevention of bloodstream infection.
   Lancet. 2016;388:2235.
   PubMed     Text format    
   
   
   
10. GILBERT RE, Mok Q, Millar M, Blundell M, et al
    Antibiotic-impregnated catheters for prevention of bloodstream infection - Authors' reply.
    Lancet. 2016;388:2235-2236.
    PubMed     Text format    
    
    
    October 2016
11. FINN AV, Virmani R
    Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32063.
    PubMed     Text format    
    
    
    
12. MACK M, Holmes DR
    Randomised trials in left main disease: a NOBLE effort.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32067.
    PubMed     Text format    
    
    
    
13. VON BIRGELEN C, Kok MM, van der Heijden LC, Danse PW, et al
    Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31920.
    PubMed     Text format     Abstract available
    
    
    
14. ALI ZA, Maehara A, Genereux P, Shlofmitz RA, et al
    Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)31922.
    PubMed     Text format     Abstract available
    
    
    
15. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available
    
    
    
16. ISAAZ K, Gerbay A
    Deferred stenting in acute ST elevation myocardial infarction.
    Lancet. 2016;388:1371.
    PubMed     Text format    
    
    
    
17. KELBAEK H, Hofsten DE, Engstrom T, Helqvist S, et al
    Deferred stenting in acute ST elevation myocardial infarction - Authors' reply.
    Lancet. 2016;388:1371-1372.
    PubMed     Text format    
    
    
    August 2016
18. CAYLA G, Cuisset T, Silvain J, Leclercq F, et al
    Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31323.
    PubMed     Text format     Abstract available
    
    
    
19. WEINTRAUB WS
    Invasive management of acute coronary syndromes.
    Lancet. 2016 Aug 25. pii: S0140-6736(16)31273.
    PubMed     Text format    
    
    
    
20. DALE A, Drysdale H, Heneghan C
    The CHAMPION trial outcomes were not adequately prespecified.
    Lancet. 2016;388:564.
    PubMed     Text format    
    
    
    
21. REED GW, Rossi JE, Cannon CP
    Acute myocardial infarction.
    Lancet. 2016 Aug 5. pii: S0140-6736(16)30677.
    PubMed     Text format     Abstract available
    
    
    
22. AITKEN E, Jackson A, Kearns R, Steven M, et al
    Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial.
    Lancet. 2016 Aug 1. pii: S0140-6736(16)30948.
    PubMed     Text format     Abstract available
    
    
    
23. MAMODE N, Calder F
    Improving outcomes in dialysis fistulae.
    Lancet. 2016 Aug 1. pii: S0140-6736(16)31230.
    PubMed     Text format    
    
    
    June 2016
24. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive strategy in acute coronary syndrome - Authors' reply.
    Lancet. 2016;387:2504.
    PubMed     Text format    
    
    
    
25. MATHEW ST, Pakala AV, Thadani U
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503-4.
    PubMed     Text format    
    
    
    
26. SHAH R
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    
    
    
    
27. TIMMIS A
    Invasive strategy in acute coronary syndrome.
    Lancet. 2016;387:2503.
    PubMed     Text format    
    
    
    
28. DALE A, Slade E, Heneghan C
    Outcomes reporting of the FAME trial.
    Lancet. 2016;387:2292.
    PubMed     Text format    
    
    
    April 2016
29. GILBERT RE, Mok Q, Dwan K, Harron K, et al
    Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Lancet. 2016;387:1732-42.
    PubMed     Text format     Abstract available
    
    
    
30. SLADE E, Hartley P, Heneghan C
    REGULATE-PCI trial.
    Lancet. 2016;387:1510.
    PubMed     Text format    
    
    
    
31. LINCOFF AM, Alexander JH, Mehran R
    REGULATE-PCI trial--Author's reply.
    Lancet. 2016;387:1510-1.
    PubMed     Text format    
    
    
    
32. VAN 'T HOF AW, Ottervanger JP
    Primary angioplasty for STEMI: hard to improve upon.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30123.
    PubMed     Text format    
    
    
    
33. KELBAEK H, Hofsten DE, Kober L, Helqvist S, et al
    Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Lancet. 2016 Apr 1. pii: S0140-6736(16)30072.
    PubMed     Text format     Abstract available
    
    
    March 2016
34. NAYLOR AR
    Age and carotid intervention outcomes.
    Lancet. 2016;387:1255-7.
    PubMed     Text format    
    
    
    February 2016
35. MUIR KW, White P
    HERMES: messenger for stroke interventional treatment.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00351.
    PubMed     Text format    
    
    
    
36. GOYAL M, Menon BK, van Zwam WH, Dippel DW, et al
    Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
    Lancet. 2016 Feb 18. pii: S0140-6736(16)00163.
    PubMed     Text format     Abstract available
    
    
    
37. HOWARD G, Roubin GS, Jansen O, Hendrikse J, et al
    Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials.
    Lancet. 2016 Feb 12. pii: S0140-6736(15)01309.
    PubMed     Text format     Abstract available
    
    
    
38. CASSESE S, Byrne RA, Ndrepepa G, Kufner S, et al
    Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
    Lancet. 2016;387:537-44.
    PubMed     Text format     Abstract available
    
    
    January 2016
39. VERHEUGT FW
    An anticoagulant too good to be true for revascularisation.
    Lancet. 2016;387:314-5.
    PubMed     Text format    
    
    
    
40. PSALTIS PJ, Nicholls SJ
    Management of acute coronary syndrome in the very elderly.
    Lancet. 2016 Jan 12. pii: S0140-6736(16)00036.
    PubMed     Text format    
    
    
    
41. TEGN N, Abdelnoor M, Aaberge L, Endresen K, et al
    Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Lancet. 2016 Jan 12. pii: S0140-6736(15)01166.
    PubMed     Text format     Abstract available
    
    
    
42. FROBERT O, James SK
    Coronary thrombus aspiration: a lesson for clinical medicine.
    Lancet. 2016;387:97-8.
    PubMed     Text format    
    
    
    December 2015
43. VALGIMIGLI M, Gargiullo G, Juni P
    Radial versus femoral access for cardiac catheterisation - Authors' reply.
    Lancet. 2015;386:2394.
    PubMed     Text format    
    
    
    
44. BRIEGER D, Yong A
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2393-4.
    PubMed     Text format    
    
    
    
45. SHAH R, Gardner JD
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392-3.
    PubMed     Text format    
    
    
    
46. DOWLING C, Rao S, Kerr N, Muller D, et al
    Radial versus femoral access for cardiac catheterisation.
    Lancet. 2015;386:2392.
    PubMed     Text format    
    
    
    November 2015
47. DELEWI R, Piek JJ
    Cardiac catheterisation: radiation for radialists.
    Lancet. 2015;386:2123-4.
    PubMed     Text format    
    
    
    
48. LOBO MD, Sobotka PA, Dolan E, Witkowski A, et al
    Central arteriovenous anastomosis and hypertension - Authors' reply.
    Lancet. 2015;386:1821-2.
    PubMed     Text format    
    
    
    
49. DEINUM J, Wetzels JF
    Central arteriovenous anastomosis and hypertension.
    Lancet. 2015;386:1821.
    PubMed     Text format    
    
    
    
50. LINCOFF AM, Mehran R, Povsic TJ, Zelenkofske SL, et al
    Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00515.
    PubMed     Text format     Abstract available
    
    
    October 2015
51. HEAD SJ, Kappetein AP
    Coronary artery disease: a dam in the river for ranolazine.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00458.
    PubMed     Text format    
    
    
    
52. JOLLY SS, Cairns JA, Yusuf S, Rokoss MJ, et al
    Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00448.
    PubMed     Text format     Abstract available
    
    
    
53. WEISZ G, Genereux P, Iniguez A, Zurakowski A, et al
    Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00459.
    PubMed     Text format     Abstract available
    
    
    
54. HAUDE M, Ince H, Abizaid A, Toelg R, et al
    Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
    Lancet. 2015 Oct 9. pii: S0140-6736(15)00447.
    PubMed     Text format     Abstract available
    
    
    September 2015
55. PLOURDE G, Pancholy SB, Nolan J, Jolly S, et al
    Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2015 Sep 24. pii: S0140-6736(15)00305.
    PubMed     Text format     Abstract available
    
    
    
56. MIMOZ O, Lucet JC, Kerforne T, Pascal J, et al
    Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial tr
    Lancet. 2015 Sep 17. pii: S0140-6736(15)00244.
    PubMed     Text format     Abstract available
    
    
    August 2015
57. SEDLIS SP, Lorin JD
    Percutaneous coronary intervention: FAME is lasting.
    Lancet. 2015 Aug 28. pii: S0140-6736(15)00044.
    PubMed     Text format    
    
    
    
58. VAN NUNEN LX, Zimmermann FM, Tonino PA, Barbato E, et al
    Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
    Lancet. 2015 Aug 28. pii: S0140-6736(15)00057.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: